Stay updated on Remibrutinib Long-term Extension in Urticaria Clinical Trial
Sign up to get notified when there's something new on the Remibrutinib Long-term Extension in Urticaria Clinical Trial page.

Latest updates to the Remibrutinib Long-term Extension in Urticaria Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision: v3.6.4 replaces the previous v3.6.3 on the page, indicating a new build. The update does not change displayed information or layout.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page's revision label has been updated from v3.6.2 to v3.6.3, indicating a new release of the page.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a small update to the page’s version. This most likely reflects backend or formatting adjustments rather than substantive changes to the study details.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page adds a recruitment status note indicating that no participants are currently being sought and introduces new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study). It also standardizes the Intervention/Treatment header formatting and updates the page revision from v3.5.5 to v3.6.0.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a software update. This change does not affect the study details or other user-visible information.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page shows a new Revision label, updating from v3.5.3 to v3.5.4, indicating a small build-level update.SummaryDifference0.0%

Stay in the know with updates to Remibrutinib Long-term Extension in Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Remibrutinib Long-term Extension in Urticaria Clinical Trial page.